You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AXSM Sale Disclosure
Tabuteau Herriot · SEC Form 4 · Filed Jun 9, 2026
Sale
Calculated transaction value
$11.97M
Tabuteau Herriot Chief Executive Officer
AXSM
Axsome Therapeutics
AXSM
Transaction date
Jun 9, 2026
Public filing date
Jun 9, 2026
Filing lag
Filed same day
AXSM daily price context
Close on/before transaction
$245.64
Jun 9, 2026
First close after public filing
$246.34
Jun 10, 2026
30-day return after filing
+1.06%
Through Jul 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 49,670 shares @ $241.01
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-264038
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$12.22M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Axsome Therapeutics, Inc. AXSM | Exercise | Jun 9, 2026 | $245.87K |
| Axsome Therapeutics, Inc. AXSM Current | Sale | Jun 9, 2026 | $11.97M |
| Axsome Therapeutics, Inc. AXSM | Exercise | Jun 9, 2026 | $0 |